[53] Tirzepatide's efficacy for chronic weight management (weight reduction and maintenance) in combination with a reduced-calorie diet and increased physical activity was established in two randomized, double-blind, placebo-controlled trials in adults with obesity or overweight who had at least one weight-related condition
Ashraf Adly El-Sheikh chairman of ADC center (Abou-Seifien Diabetes Center) in Egypt for his patience, motivation, enthusiasm and immense knowledge
(6) Fragment 176-191 & CJC-1295 & Ipamorelin Blend, and Lipolytic Action A clinical trial (7) was conducted in 2004 to study the peptides potential lipolytic (fat-burning) action
(PubMed) McNulty H, Strain JJ, Hughes CF, Pentieva K, Ward M
Current clinical guidelines recommend discontinuing tirzepatide at least three months before attempting pregnancy, though individual circumstances vary based on medical history and weight loss goals